A Comprehensive Analysis of Risk Factors of Diabetic Nephropathy and Exploring the Treatment Pattern

Aritra Pal, Asish Bhanja, Joy Williams, Vineesha Geddam, Chandana Bendurthi, Bipin Sah, Bashongdor Marwein, Arka Ghosh, Anurag Rajkonwar, Praveen Sana, Ratna Kumari
{"title":"A Comprehensive Analysis of Risk Factors of Diabetic Nephropathy and Exploring the Treatment Pattern","authors":"Aritra Pal, Asish Bhanja, Joy Williams, Vineesha Geddam, Chandana Bendurthi, Bipin Sah, Bashongdor Marwein, Arka Ghosh, Anurag Rajkonwar, Praveen Sana, Ratna Kumari","doi":"10.9734/jpri/2024/v36i57516","DOIUrl":null,"url":null,"abstract":"Aims: The study aims to comprehensively analyze diabetic nephropathy's risk factors and treatment patterns, exploring diverse factors for enhanced prevention and personalized management. \nStudy Design: Prospective study design. \nPlace and Duration of Study: The study was conducted for 5 months at Trust Multispeciality Hospital, Kakinada. \nMethodology: This retroactive chart analysis of non-critical outpatients folders of Trust Hospital that refers to the mentioned period (11/2022 -04/2023) will use Excel software. \nResults: A variety of risk factors promote the development and progression of diabetic nephropathy, including elevated glucose levels, high blood pressure, obesity, the long duration of diabetes, and dyslipidemia. These risk factors are modifiable by hyperglycemic agents, anti-hypertensives, and lipid-lowering agents. Most of the people who are prone to diabetic nephropathy are between 40 and 70 years of age. Males are most affected (80%) compared to females (20%). Oral hypoglycemic agents (97%) and calcium channel blockers (50%) play a major role in reducing the progression of diabetic nephropathy by controlling blood pressure and glucose levels in the subject. Obesity is also a notable risk factor for end-stage renal disease patients.","PeriodicalId":506675,"journal":{"name":"Journal of Pharmaceutical Research International","volume":" 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Research International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/jpri/2024/v36i57516","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: The study aims to comprehensively analyze diabetic nephropathy's risk factors and treatment patterns, exploring diverse factors for enhanced prevention and personalized management. Study Design: Prospective study design. Place and Duration of Study: The study was conducted for 5 months at Trust Multispeciality Hospital, Kakinada. Methodology: This retroactive chart analysis of non-critical outpatients folders of Trust Hospital that refers to the mentioned period (11/2022 -04/2023) will use Excel software. Results: A variety of risk factors promote the development and progression of diabetic nephropathy, including elevated glucose levels, high blood pressure, obesity, the long duration of diabetes, and dyslipidemia. These risk factors are modifiable by hyperglycemic agents, anti-hypertensives, and lipid-lowering agents. Most of the people who are prone to diabetic nephropathy are between 40 and 70 years of age. Males are most affected (80%) compared to females (20%). Oral hypoglycemic agents (97%) and calcium channel blockers (50%) play a major role in reducing the progression of diabetic nephropathy by controlling blood pressure and glucose levels in the subject. Obesity is also a notable risk factor for end-stage renal disease patients.
糖尿病肾病风险因素综合分析及治疗模式探讨
研究目的:本研究旨在全面分析糖尿病肾病的危险因素和治疗模式,探讨加强预防和个性化管理的各种因素。研究设计:前瞻性研究设计。研究地点和时间:研究在卡基纳达信托多专科医院进行,为期 5 个月。研究方法:使用 Excel 软件对上述期间(2022 年 11 月至 2023 年 4 月)信托医院非危重门诊病人折叠病历进行追溯分析。结果多种风险因素会促进糖尿病肾病的发生和发展,包括血糖水平升高、高血压、肥胖、糖尿病病程长和血脂异常。这些风险因素可以通过降糖药、降压药和降脂药来改变。易患糖尿病肾病的大多数人年龄在 40 岁至 70 岁之间。与女性(20%)相比,男性患者最多(80%)。口服降糖药(97%)和钙通道阻滞剂(50%)通过控制受试者的血压和血糖水平,在减少糖尿病肾病进展方面发挥着重要作用。肥胖也是终末期肾病患者的一个显著风险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信